These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 24262199)

  • 21. DJ-1 as a Biomarker of Parkinson's Disease.
    Saito Y
    Adv Exp Med Biol; 2017; 1037():149-171. PubMed ID: 29147908
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.
    Teixeira Dos Santos MC; Bell R; da Costa AN
    Bioanalysis; 2016 Dec; 8(23):2497-2518. PubMed ID: 27855513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated Plasma and Neuroimaging Biomarkers Associated with Motor and Cognition Severity in Parkinson's Disease.
    Chen CH; Lee BC; Lin CH
    J Parkinsons Dis; 2020; 10(1):77-88. PubMed ID: 31868681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CSF or serum neurofilament light added to α-Synuclein panel discriminates Parkinson's from controls.
    Oosterveld LP; Verberk IMW; Majbour NK; El-Agnaf OM; Weinstein HC; Berendse HW; Teunissen CE; van de Berg WDJ
    Mov Disord; 2020 Feb; 35(2):288-295. PubMed ID: 31737952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease.
    Foulds PG; Diggle P; Mitchell JD; Parker A; Hasegawa M; Masuda-Suzukake M; Mann DM; Allsop D
    Sci Rep; 2013; 3():2540. PubMed ID: 23985836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of distinct blood-based biomarkers in early stage of Parkinson's disease.
    Wu Y; Yao Q; Jiang GX; Wang G; Cheng Q
    Neurol Sci; 2020 Apr; 41(4):893-901. PubMed ID: 31828678
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unequivocal Biomarker for Parkinson's Disease: A Hunt that Remains a Pester.
    Sarkar A; Rawat N; Sachan N; Singh MP
    Neurotox Res; 2019 Oct; 36(3):627-644. PubMed ID: 31267488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers in Parkinson's disease: a funder's perspective.
    Frasier M; Chowdhury S; Eberling J; Sherer T
    Biomark Med; 2010 Oct; 4(5):723-9. PubMed ID: 20945984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.
    Yanamandra K; Gruden MA; Casaite V; Meskys R; Forsgren L; Morozova-Roche LA
    PLoS One; 2011 Apr; 6(4):e18513. PubMed ID: 21541339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Proteomics in Human Parkinson's Disease: Present Scenario and Future Directions.
    Dixit A; Mehta R; Singh AK
    Cell Mol Neurobiol; 2019 Oct; 39(7):901-915. PubMed ID: 31190159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Problems associated with fluid biomarkers for Parkinson's disease.
    Nyhlén J; Constantinescu R; Zetterberg H
    Biomark Med; 2010 Oct; 4(5):671-81. PubMed ID: 20945980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma Extracellular Vesicle α-Synuclein Level in Patients with Parkinson's Disease.
    Chung CC; Chan L; Chen JH; Hung YC; Hong CT
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34067663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of RNA Blood Biomarkers in Individuals at Risk of Parkinson's Disease.
    Santiago JA; Potashkin JA
    J Parkinsons Dis; 2017; 7(4):653-660. PubMed ID: 28922168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central Nervous System-Derived Exosomal Alpha-Synuclein in Serum May Be a Biomarker in Parkinson's Disease.
    Si X; Tian J; Chen Y; Yan Y; Pu J; Zhang B
    Neuroscience; 2019 Aug; 413():308-316. PubMed ID: 31102760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biomarkers of Parkinson's disease: present and future.
    Miller DB; O'Callaghan JP
    Metabolism; 2015 Mar; 64(3 Suppl 1):S40-6. PubMed ID: 25510818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular markers of early Parkinson's disease based on gene expression in blood.
    Scherzer CR; Eklund AC; Morse LJ; Liao Z; Locascio JJ; Fefer D; Schwarzschild MA; Schlossmacher MG; Hauser MA; Vance JM; Sudarsky LR; Standaert DG; Growdon JH; Jensen RV; Gullans SR
    Proc Natl Acad Sci U S A; 2007 Jan; 104(3):955-60. PubMed ID: 17215369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blood RNA biomarkers in prodromal PARK4 and rapid eye movement sleep behavior disorder show role of complexin 1 loss for risk of Parkinson's disease.
    Lahut S; Gispert S; Ömür Ö; Depboylu C; Seidel K; Domínguez-Bautista JA; Brehm N; Tireli H; Hackmann K; Pirkevi C; Leube B; Ries V; Reim K; Brose N; den Dunnen WF; Johnson M; Wolf Z; Schindewolf M; Schrempf W; Reetz K; Young P; Vadasz D; Frangakis AS; Schröck E; Steinmetz H; Jendrach M; Rüb U; Başak AN; Oertel W; Auburger G
    Dis Model Mech; 2017 May; 10(5):619-631. PubMed ID: 28108469
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of blood-based biomarkers for diagnosis and prognosis of Parkinson's disease: A systematic review of proteomics studies.
    Chelliah SS; Bhuvanendran S; Magalingam KB; Kamarudin MNA; Radhakrishnan AK
    Ageing Res Rev; 2022 Jan; 73():101514. PubMed ID: 34798300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma near-infrared spectroscopy for diagnosis of idiopathic Parkinson's disease: the SPIN-PD study.
    Ravina B; Eberly S; Oakes D; Lang AE; Dodelet V; Roos P; Harman J; Shoulson I; Schipper HM
    Biomark Med; 2015; 9(2):89-97. PubMed ID: 25689898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CSF and blood biomarkers for Parkinson's disease.
    Parnetti L; Gaetani L; Eusebi P; Paciotti S; Hansson O; El-Agnaf O; Mollenhauer B; Blennow K; Calabresi P
    Lancet Neurol; 2019 Jun; 18(6):573-586. PubMed ID: 30981640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.